Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer - Vivas-Mejia, P E; Rodriguez-Aguayo, C; Han, H D; Shahzad, M M; Valiyeva, F; Shibayama, M; Chavez-Reyes, A; Sood, A K; Lopez-Berestein, G (Clin Cancer Res, 2011)